Form 4 holding
CEO and President, Director
RECURSION PHARMACEUTICALS, INC.
- Security class
- Class A Common Stock
- Shares / value
- 2,072,890
- Estimated value
- $7,291,597
- Report date
- 08 Sep 2026
- Price
- $3.52
- Ownership
- Direct